| Literature DB >> 35400134 |
Gang Zou1, Jun Zhang2, Qifan Yang1, Xiaoyan Wang3, Pengpeng Sun1.
Abstract
Osteochondral lesion is clinically common disease, which has been recognized as one of the contributing factors of significant morbidity. Although current treatments have achieved good outcomes, some undesirable complications and failures are not uncommon. Cell sheet technology (CST), an innovative technology to harvest seed cells and preserve abundant ECM, has been widely used in various tissue regeneration. For osteochondral lesion, many studies focus on using CST to repair osteochondral lesion and have achieved good outcomes. In the previous study, we have demonstrated that hAMSC sheet had a positive effect on osteochondral lesion. Therefore, this study is aimed at comparing the effect of noninduced hAMSC sheet with chondrogenically induced hAMSC sheet on osteochondral lesion and cartilage regeneration.Entities:
Year: 2022 PMID: 35400134 PMCID: PMC8989589 DOI: 10.1155/2022/3967722
Source DB: PubMed Journal: Stem Cells Int Impact factor: 5.443
Figure 1The schematic diagram of the experimental operation. (a) Harvesting human amniotic membrane from placentas. (b) Isolating hAMSCs from the human amniotic membrane of placentas by twice digestion with trypsin and once digestion with collagenase type II. (c) Fabricating hAMSC sheet by adding 50 μg/ml vitamin C into cell sheet induction medium. (d) Fabricating chondrogenically induced hAMSC sheet by changing for cell sheet induction medium for chondrogenic induction medium. (e) Creating rabbit osteochondral defects in the center of the femoral trochlear groove and the osteochondral defects were treated with nothing, noninduced cell sheet and chondrogenically induced cell sheet. hAMSCs: human amniotic mesenchymal stem cells.
Primer sequences for quantitative RT-PCR analysis.
| Gene name | Gene symbol | Primer sequence | Accession number |
|---|---|---|---|
| Sex determining region | SOX9 | F:TAAAGGCAACTCGTACCCAA | NM_000346.3 |
| Y-box 9 | R:ATTCTCCATCATCCTCCACG | ||
| Collagen type II | COLII | F:CCTCTGCGACGACATAATCT | NM_001844.4 |
| R:CTCCTTTCTGTCCCTTTGGT | |||
| Glyceraldehyde-3-phosphate dehydrogenase | NM_002046.4 | ||
| GAPDH | F:GCCTTCCGTGTCCCCACTGC | ||
| R:CAATGCCAGCCCCAGCGTCA |
Figure 2The operative process of creation osteochondral defects. (a) Exposing the articular surfaces of the trochlear grooves. (b)–(d) Creating osteochondral defects at the right knee joints (diameter: 3.5 mm; depth: 3 mm).
O'Driscoll histological cartilage repair score.
| Characteristics | Score |
|---|---|
| Nature of predominant tissue | |
| Cellular morphology | |
| Hyaline articular cartilage | 4 |
| Incompletely differentiated mesenchymal | 2 |
| Fibrous tissue or bone | 0 |
| Safranin O staining of the matrix | |
| Normal or nearly normal | 3 |
| Moderate | 2 |
| Slight | 1 |
| None | 0 |
| Structure characteristics | |
| Surface regularity | |
| Smooth and intact | 3 |
| Superficial horizontal lamination | 2 |
| Fissures 25% to 100% of the thickness | 1 |
| Severe disruption including fibrillation | 0 |
| Structural integrity | |
| Normal | 2 |
| Slight disruption including cysts | 1 |
| Severe disintegration | 0 |
| Thickness | |
| 100% of normal adjacent cartilage | 2 |
| 50% to 100% of normal cartilage | 1 |
| 0% to 50% of normal cartilage | 0 |
| Bonding to the adjacent cartilage | |
| Bonded at both ends of graft | 2 |
| Bonded at one end or partially at both ends | 1 |
| Not bonded | 0 |
| Freedom from cellular changes of degeneration | |
| Hypocellularity | |
| Normal cellularity | 3 |
| Slight hypocellularity | 2 |
| Moderate hypocellularity | 1 |
| Severe hypocellularity | 0 |
| Chondrocyte clustering | |
| No clusters | 2 |
| <25% of the cells | 1 |
| 25% to 100 of the cells | 0 |
| Freedom from degenerative changes in adjacent cartilage | |
| Normal cellularity, no clusters, normal staining | 3 |
| Normal cellularity, mild clusters, slight staining | 2 |
| Mild or moderate hypocellularity, slight staining | 1 |
| Severe hypocellularity, poor or no staining | 0 |
| Total | 24 |
Figure 3(a) Microscopic observations of hAMSCs. (A) P0 hAMSCs. (B) P3 hAMSCs. Scale bar: 200 μm. (b) Multidirectional differentiation potential for osteogenic and chondrogenic differentiation of passage 3 hAMSCs. (A) Osteogenic differentiation (alzarin red staining). (B) Chondrogenic differentiation (alcian blue staining). Scale bar: 100 μm.
Figure 4Preparation and characterization of hAMSCs sheet. (a) Gross appearance of the hAMSC sheet derived from hAMSCs and the cell sheet could be folded to an oblong-shaped flap. (b) hAMSC sheet was observed under inverted phase contrast microscope. Many long spindle-shaped cells were closely arranged and evenly distributed. (c) Live/dead staining of the cell sheet. Green indicated live cells and red indicated dead cells. (d) SEM of cell sheet. Cells were embedded in a large amount of extracellular matrix secreted by themselves. (e) Histological analysis (HE staining) of the harvested cell sheet that was composed of multilayer cells and vast ECM.
Figure 5Chondrogenic induction of hAMSC sheet. (a) The SEM results of hAMSCs sheet induced by chondrogenic induction medium. (b) mRNA level of SOX9 and collagen type II. Compared with the noninduced group, mRNA expressions of SOX9 and collagen type II were significantly increased in the induced group on day 14 (∗∗∗∗P < .0001).
Figure 6(a) Macroscopic observations of regenerative cartilage at 12 weeks after surgery. (A) Normal articular cartilage. (B) Control group. (C) Noninduced cell sheet group. (D) Chondrogenically induced cell sheet group. (b) International Cartilage Repair Society macroscopic scores of all groups at 12 weeks after surgery. ∗∗P < .01; ∗∗∗∗P < .0001.
Figure 7(a) Histological examination of regenerated tissue in all groups at 12 weeks postoperatively. TB: toluidine blue; SO/FG: Safranin-O/Fast-green. Scale bar: 1 mm and 500 μm. (b) O'Driscoll histological scores of groups at 12 weeks postoperatively, ∗∗P < .01, ∗∗∗P < .001, ∗∗∗∗P < .0001. (c) The Mankin scores of groups at 12 weeks postoperatively, ∗P < .05, ∗∗∗P < .001, ∗∗∗∗P < .0001. (d) Immunohistochemical staining of COL-I and COL-II. Scale bar: 100 μm. RC: regenerated cartilage; NC: normal cartilage.